Snowball logo
logo
8329

Shenzhen Neptunus Interlong Bio technique Co Ltd

8329 • HK
HK$0.091HK$0.00  (0%)
Estimate
Beta
-0.076
Growth
Revenue, YoY
73.47%
Net income, YoY
-27.15%
FCF, YoY
-126.57%
About the company
Ticker
8329
ISIN
CNE100000775
Country
Hong Kong
Sector (GICS)
Healthcare
Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People's Republic of China. It operates through two segments, Manufacturing and Selling of medicines and medical devices; and Sales and Distribution of medicines and healthcare products, and medical devices. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental diseases. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited operates as a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Frequently asked questions

What sector does Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) operate in?

Shenzhen Neptunus Interlong Bio technique Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) current stock price?

As of the latest data, Shenzhen Neptunus Interlong Bio technique Co Ltd stock price is HK$0.09, with a previous close of HK$0.09.

What is Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) current market capitalization?

Shenzhen Neptunus Interlong Bio technique Co Ltd market cap is approximately 38.77 million.

What is Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) EBITDA?

Shenzhen Neptunus Interlong Bio technique Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 25.46 million.

Does Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) pay dividends?

No. Shenzhen Neptunus Interlong Bio technique Co Ltd does not pay a dividend.

What is Shenzhen Neptunus Interlong Bio technique Co Ltd (8329) beta (volatility) score?

Shenzhen Neptunus Interlong Bio technique Co Ltd has a beta of -0.076, indicating lower volatility than the overall market.